These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 37804854)

  • 1. Precision medicine of obesity as an integral part of type 2 diabetes management - past, present, and future.
    Szczerbinski L; Florez JC
    Lancet Diabetes Endocrinol; 2023 Nov; 11(11):861-878. PubMed ID: 37804854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current and Emerging Pharmacotherapies for Weight Management in Prediabetes and Diabetes.
    Lau DC; Teoh H
    Can J Diabetes; 2015 Dec; 39 Suppl 5():S134-41. PubMed ID: 26654857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obesity and type 2 diabetes.
    Maggio CA; Pi-Sunyer FX
    Endocrinol Metab Clin North Am; 2003 Dec; 32(4):805-22, viii. PubMed ID: 14711063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medical and surgical management of obesity and diabetes: what's new?
    Ammori BJ; Skarulis MC; Soran H; Syed AA; Eledrisi M; Malik RA
    Diabet Med; 2020 Feb; 37(2):203-210. PubMed ID: 31850536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New options for the treatment of obesity and type 2 diabetes mellitus (narrative review).
    Henry RR; Chilton R; Garvey WT
    J Diabetes Complications; 2013; 27(5):508-18. PubMed ID: 23726071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human Genetics of Obesity and Type 2 Diabetes Mellitus: Past, Present, and Future.
    Ingelsson E; McCarthy MI
    Circ Genom Precis Med; 2018 Jun; 11(6):e002090. PubMed ID: 29899044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic consequences of obesity and type 2 diabetes: Balancing genes and environment for personalized care.
    Pillon NJ; Loos RJF; Marshall SM; Zierath JR
    Cell; 2021 Mar; 184(6):1530-1544. PubMed ID: 33675692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Precision Medicine in Obesity and Type 2 Diabetes: The Relevance of Early-Life Exposures.
    Estampador AC; Franks PW
    Clin Chem; 2018 Jan; 64(1):130-141. PubMed ID: 29097511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in medical therapy for weight loss and the weight-centric management of type 2 diabetes mellitus.
    Igel LI; Powell AG; Apovian CM; Aronne LJ
    Curr Atheroscler Rep; 2012 Feb; 14(1):60-9. PubMed ID: 22113707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Weight Loss and the Prevention and Treatment of Type 2 Diabetes Using Lifestyle Therapy, Pharmacotherapy, and Bariatric Surgery: Mechanisms of Action.
    Grams J; Garvey WT
    Curr Obes Rep; 2015 Jun; 4(2):287-302. PubMed ID: 26627223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Precision Medicine in Weight Loss and Healthy Living.
    Severin R; Sabbahi A; Mahmoud AM; Arena R; Phillips SA
    Prog Cardiovasc Dis; 2019; 62(1):15-20. PubMed ID: 30610881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Precision behavioral medicine: Implications of genetic and genomic discoveries for behavioral weight loss treatment.
    McCaffery JM
    Am Psychol; 2018 Nov; 73(8):1045-1055. PubMed ID: 30394782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obesity and type 2 diabetes: a conflict of interests?
    Williams G
    Int J Obes Relat Metab Disord; 1999 Jun; 23 Suppl 7():S2-4. PubMed ID: 10455464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Obesity and type 2 diabetes: Also linked in therapeutic options.
    Rubio-Almanza M; Cámara-Gómez R; Merino-Torres JF
    Endocrinol Diabetes Nutr (Engl Ed); 2019 Mar; 66(3):140-149. PubMed ID: 30337188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of diabetes and associated cardiometabolic risk factors on members: strategies for optimizing outcomes.
    Hoerger TJ; Ahmann AJ
    J Manag Care Pharm; 2008 Feb; 14(1 Suppl C):S2-14; quiz 15-6. PubMed ID: 18240890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment modalities of obesity: what fits whom?
    Hainer V; Toplak H; Mitrakou A
    Diabetes Care; 2008 Feb; 31 Suppl 2():S269-77. PubMed ID: 18227496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiobesity drugs in the management of type 2 diabetes: A shift in thinking?
    Burguera B; Ali KF; Brito JP
    Cleve Clin J Med; 2017 Jul; 84(7 Suppl 1):S39-S46. PubMed ID: 28708481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetics of type 2 diabetes mellitus and weight change - a tool for precision medicine?
    Ling C; Bacos K; Rönn T
    Nat Rev Endocrinol; 2022 Jul; 18(7):433-448. PubMed ID: 35513492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nutritional management of type 2 diabetes mellitus and obesity and pharmacologic therapies to facilitate weight loss.
    Vetter ML; Amaro A; Volger S
    Postgrad Med; 2014 Jan; 126(1):139-52. PubMed ID: 24393761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Challenges in the treatment of patients with type 2 diabetes mellitus and obesity].
    Manzanares Errazu JM
    Nutr Hosp; 2002 Feb; 17 Suppl 1():1-6. PubMed ID: 11928531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.